Back to Trials
NCT02693509RecruitingAccepts Healthy Volunteers

Get With The Guidelines-Heart Failure Registry

American Heart Association

Start Date

1/1/2005

Completion Date

1/1/2040

Summary

Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Detailed Description

Get With The Guidelines-Heart Failure was initiated in 2005 with over 500 U.S. hospitals participating is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge. Peer-reviewed research(with over 35 manuscripts) has demonstrated that through participating in Get With The Guidelines-Heart Failure, hospitals will provide equitable care (regardless of race, ethnicity, age, or gender), the importance of scheduled physician follow-up after heart failure hospital discharge, the value in device-support as necessary for the acute heart failure patient, and many other significant findings. Achievement measures tracked through Get With The Guidelines-Heart Failure: * Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) at discharge * Evidence-based specific beta blockers * Measure left ventricular function * Post-discharge appointment for heart failure patients Quality Measures tracked through Get With The Guidelines-Heart Failure: * Mineralocorticoid receptor antagonist at discharge * Aldosterone antagonist at discharge * Anticoagulation for atrial fibrillation * Hydralazine nitrate at discharge * DVT prophylaxis * CRT-D or CRT-P placed or prescribed at discharge * ICD counseling, or ICD placed or prescribed at discharge * Influenza vaccination during flu season * Pneumococcal vaccination * Follow-up visit within 7 days or less * Lab monitoring follow-up * SGLT-2 inhibitor at discharge * Defect-free care for quadruple therapy medication for patients with heart failure with reduced ejection fraction * Direct-acting oral anticoagulant at discharge for non-valvular atrial fibrillation or atrial flutter patients Additional measures collected by Get With The Guidelines-Heart Failure can be viewed at: http://www.heart.org/idc/groups/heart-public/@wcm/@private/@hcm/@gwtg/documents/downloadable/ucm\_310967.pdf

Eligibility Criteria

Age Range: 18 years to 125 years

Inclusion Criteria: * Patients hospitalized with congestive heart failure. Exclusion Criteria: * Patients who do not have congestive heart failure, * Patients under age of 18, * Patients not admitted as inpatients.

Interventions

OTHER

GWTG Heart Failure program

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Heart Failure

Locations

Amy Bennett

Dallas, Texas 75231

United States